View in EDS PDF Full Text

Xiao Ke Qing improves glycometabolism and ameliorates insulin resistance by regulating the PI3K/Akt pathway in KKAy mice.

Saved in:
Bibliographic Details
Title: Xiao Ke Qing improves glycometabolism and ameliorates insulin resistance by regulating the PI3K/Akt pathway in KKAy mice.
Authors: Li X; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China., Li X; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China. lixx@tasly.com., Wang G; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China., Xu Y; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China., Wang Y; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China., Hao R; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China., Ma X; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China.
Source: Frontiers of medicine [Front Med] 2018 Dec; Vol. 12 (6), pp. 688-696. Date of Electronic Publication: 2018 Nov 13.
Publication Type: Journal Article
Journal Info: Publisher: Higher Education Press Country of Publication: China NLM ID: 101549428 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2095-0225 (Electronic) Linking ISSN: 20950217 NLM ISO Abbreviation: Front Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30421394
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Xiao Ke Qing improves glycometabolism and ameliorates insulin resistance by regulating the PI3K/Akt pathway in KKAy mice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China. lixx@tasly.com.<br /><searchLink fieldCode="AU" term="%22Wang+G%22">Wang G</searchLink>; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China.<br /><searchLink fieldCode="AU" term="%22Xu+Y%22">Xu Y</searchLink>; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China.<br /><searchLink fieldCode="AU" term="%22Hao+R%22">Hao R</searchLink>; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China.<br /><searchLink fieldCode="AU" term="%22Ma+X%22">Ma X</searchLink>; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101549428%22">Frontiers of medicine</searchLink> [Front Med] 2018 Dec; Vol. 12 (6), pp. 688-696. <i>Date of Electronic Publication: </i>2018 Nov 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Higher+Education+Press%22">Higher Education Press </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>101549428 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2095-0225 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220950217%22">20950217 </searchLink><i>NLM ISO Abbreviation: </i>Front Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30421394
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s11684-018-0662-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 688
    Titles:
      – TitleFull: Xiao Ke Qing improves glycometabolism and ameliorates insulin resistance by regulating the PI3K/Akt pathway in KKAy mice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Li X
      – PersonEntity:
          Name:
            NameFull: Li X
      – PersonEntity:
          Name:
            NameFull: Wang G
      – PersonEntity:
          Name:
            NameFull: Xu Y
      – PersonEntity:
          Name:
            NameFull: Wang Y
      – PersonEntity:
          Name:
            NameFull: Hao R
      – PersonEntity:
          Name:
            NameFull: Ma X
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2018 Dec
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 2095-0225
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Frontiers of medicine
              Type: main
ResultId 1